Dr. Hayden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 S Paulina St
Ste 143
Chicago, IL 60612Phone+1 312-942-2061Fax+1 312-942-2184
Education & Training
- Rush University Medical CenterFellowship, Infectious Disease, 1990 - 1993
- University of ChicagoResidency, Internal Medicine, 1987 - 1990
- University of Minnesota Medical SchoolClass of 1987
Certifications & Licensure
- IL State Medical License 1987 - 2026
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Hub Cleansing to Prevent Hub Infection Start of enrollment: 2012 Mar 01
- Active Bathing to Eliminate Infection (ABATE Infection) Trial Start of enrollment: 2014 Apr 01
- Nasal Antisepsis for C. Auris Prevention Start of enrollment: 2024 Jan 29
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 36 citationsEffectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetoba...Anucha Apisarnthanarak, Uayporn Pinitchai, Boonyasit Warachan, David K. Warren, Thana Khawcharoenporn
American Journal of Infection Control. 2014-02-01 - 212 citationsChlorhexidine Gluconate to Cleanse Patients in a Medical Intensive Care Unit: The Effectiveness of Source Control to Reduce the Bioburden of Vancomycin-Resistant Enter...Michael O. Vernon, Mary K. Hayden, William E. Trick, Robert Hayes, Donald Blom
Archives of Internal Medicine. 2006-02-13 - 165 citationsTransfer of vancomycin-resistant enterococci via health care worker hands.Amy N. Duckro, Donald Blom, Elizabeth A. Lyle, Robert A. Weinstein, Mary K. Hayden
Archives of Internal Medicine. 2005-02-14
Journal Articles
- Effect of Piperacillin-Tazobactam vs Meropenem in Escherichia Coli or Klebsiella Pneumoniae InfectionSarah Y Won, Mary K Hayden, JAMA
Press Mentions
- Chicago Medical Expert Sounds Alarm over Drug-Resistant Candida Auris Fungal InfectionsMarch 21st, 2023
- Will We See Another COVID-19 Surge This Spring?March 23rd, 2022
- Hospital Worker Vaccination Rate Data Withheld Until OctoberMarch 1st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: